Please assess the completion status of the following clinical trial:

Trial Title: Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Body mass index (BMI) score is greater than 18.5 and less than 29.9 - normal to overweight, but not obese.~* Willingness to refrain from a change in diet/drinking/exercise/medication regimen for the entire course of the study.~* For female of child bearing potential - using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study (i.e., oral contraceptives, Intra Uterine Device (IUD), contraceptive implant, barrier methods with spermicide, or abstinence).~Exclusion Criteria:~* Pregnant or planning to become pregnant, having given birth less than 9 months ago, and/or breastfeeding.~* Having any active electrical implant anywhere in the body,~* Having a permanent implant in the treated areas~* Having received treatment with laser, RF or other devices in the treated areas within 6 months of treatment or during the study.~* Having undergone a liposuction surgery or any contouring treatment in the areas intended for treatment within 2 years of treatment~* Having or undergoing any form of cancer~* Suffering from significant concurrent illness, such as cardiac disorders, diabetes (type I or II), lupus, porphyria, or pertinent neurological disorders.~* Having a anticoagulative or thromboembolic condition or taking anticoagulation medications~* History of immunosuppression/immune deficiency disorders~* Suffering from hormonal imbalance which may affect weight or cellulite~* History of significant lymphatic drainage problems.~* History of keloid scarring or of abnormal wound healing.~* History of being especially prone to bruising.~* History of epidermal or dermal disorders~* Use of isotretinoin within 6 months~* Significant change in diet or exercise regimen within a month of enrollment or during this study and/or weight loss or gain of 10 lbs (4.5 kgs) within 2 months of enrollment or during this study.~* Participation in a study of another device or drug within 1 month prior to enrollment or during this study.~* As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): Group treated with the active Venus Versa octipolar applicator and the glycerine gel.
- Control Group (Type: SHAM_COMPARATOR): Group treated with the inactive Venus Versa octipolar applicator and the glycerine gel.

Based on this trial design, predict the completion outcome and termination type (if applicable).